As shown in Figure 1, which is an excerpt of the study “68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancers” by Kratochwil et al., FAP-targeting possesses a pan-tumor applicability. This evidence concerns the gene FAP and neoplasm.